Alphabet and Facebook Trade Higher before European Union Copyright Reforms

Alphabet and Facebook Trade Higher before European Union Copyright Reforms

Alphabet and Facebook traded higher before the European Union’s executive branch proposes a broad package of copyright reforms this week, according to media reports. Among other things, the proposals are expected to help musicians and their record companies earn more by making streaming services such as YouTube beef up their ability to fight piracy, according to a report from the Wall Street Journal. The rules may, however, also mean Google […]

Read More ˃
Southwestern Energy Outlook Revised to Stable by Fitch Ratings

Southwestern Energy Outlook Revised to Stable by Fitch Ratings

Southwestern Energy Company shares were lower 4% on Tuesday as Fitch Ratings said the ratings outlook has been revised to stable from positive while it also upgraded the company’s long-term issuer default rating to ‘BB’ from ‘B+’. Fitch said it has also upgraded Southwestern’s secured term loan to ‘BBB-‘/’RR1’ from ‘BB+’/’RR1’ and secured credit facility and unsecured debt to ‘BB’/’RR4’ from ‘B+’/’RR4’. “The upgrade reflects the company’s improved liquidity position […]

Read More ˃
Fitch Upgrades Host Hotels’ Issuer Default Rating to ‘BBB’

Fitch Upgrades Host Hotels’ Issuer Default Rating to ‘BBB’

Fitch Ratings said Friday it has upgraded the ratings of Host Hotels & Resorts (HST) and its operating partnership Host Hotels & Resorts, L.P., to ‘BBB’ from ‘BBB-‘. Fitch said that the rating outlook is stable. HST shares were down 0.1% in recent trading. The international credit ratings agency cited Host’s RevPAR growth, which it expects to be moderately below the industry average during the year due to its exposure […]

Read More ˃
SunOpta Rises 6%

SunOpta Rises 6%

SunOpta shares were higher over 6% on Thursday after Engaged Capital Flagship Fund, Ltd. said in a regulatory filing that it now holds a a 7.5% stake in the operator of businesses focused on a healthy products. Engaged Capital also that in connection with the SunOpta’s strategic review process, it is in talks with the company to assess the various strategic options available to it, how an investment by a […]

Read More ˃
BioLineRx Jumps 9%

BioLineRx Jumps 9%

BioLineRx Ltd. rose 9% in Tuesday’s afternoon trade after the company said it initiated a phase 2a trial that will evaluate BL-8040 in combination with Merck & Co.’s (MRK) Keytruda in patients with metastatic pancreatic cancer. The phase 2a study will enroll up to 30 patients with metastatic pancreatic adenocarcinoma and will be conducted in the U.S., Israel and additional territories. The study will evaluate the safety, tolerability and clinical […]

Read More ˃